Low-carbohydrate Versus Low-fat Breakfast in Type 2 Diabetes
Impact of a Low-carbohydrate Versus Low-fat Breakfast on Blood Glucose Control in Type 2 Diabetes
1 other identifier
interventional
127
1 country
1
Brief Summary
The prevalence of type 2 diabetes (T2D) is increasing worldwide, with \~380 M currently suffering from this chronic, debilitating disease. T2D is characterized by high blood glucose levels in the mornings and after meals. The largest hyperglycemic spike often occurs after breakfast. Targeting this meal may be a simple, feasible strategy to improve glycemic control and reduce risk for diabetes complications. It is hypothesized that consuming a low carbohydrate high fat (LCHF) breakfast for 3 months, when compared to a standard low-fat breakfast will improve blood glucose control, increase satiety and improve body composition in people with T2D. This information will test whether the simple dietary strategy of limiting carbohydrates at breakfast could help in managing T2D.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 15, 2020
CompletedFirst Posted
Study publicly available on registry
September 16, 2020
CompletedStudy Start
First participant enrolled
October 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2022
CompletedResults Posted
Study results publicly available
February 4, 2025
CompletedFebruary 4, 2025
February 1, 2025
1.7 years
July 15, 2020
November 1, 2022
February 2, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change From Baseline Hemoglobin A1c at 12 Weeks
Hemoglobin A1c measured at baseline and after 12 weeks of following the low-carbohydrate breakfast or low-fat breakfast
Baseline to 12 weeks of diet
Secondary Outcomes (9)
Change From Baseline Fasting Blood Glucose at 12 Weeks
Mean values for the first 14 days (weeks 1-2) and mean values for the last 14 days (weeks 11-12) of the intervention
Change From Baseline Fasting Blood Insulin at 12 Weeks
Baseline to 12 weeks of diet
Change From Baseline Blood Lipids at 12 Weeks
Baseline to 12 weeks of diet
Change From Baseline Inflammation Marker High Sensitive Reactive Protein (hsCRP) at 12 Weeks
Baseline to 12 weeks of diet
Hunger/Satiety Levels
Weeks 1, 6 and 12
- +4 more secondary outcomes
Study Arms (2)
Low-Carb High-Fat Breakfast
EXPERIMENTALParticipants will follow a daily low carbohydrate high fat breakfast intervention for 3 months.
Low fat "Standard Care" Control Breakfast
ACTIVE COMPARATORParticipants will follow a daily low fat "standard care" control breakfast intervention for 3 months.
Interventions
Participants will receive 8 low-carb high-fat breakfast meal recipes to follow daily during 3 months.
Participants will receive 8 low-fat breakfast meal recipes to follow daily during 3 months.
Eligibility Criteria
You may qualify if:
- physician-diagnosed T2D of ≥1 year;
- current HbA1c of \< 8.5%;
- BMI: \>25 kg/m2; (as of July 5, 2021, BMI cut off was expanded from 25-40 kg/m2 to higher than 25kg/m2 to facilitate recruitment)
- blood pressure of \<160/99 mm Hg assessed according to guidelines;
- non-smoking;
- not on hormone replacement therapy, corticosteroids, or anti-inflammatory medications;
- years old.
You may not qualify if:
- Use of exogenous insulin;
- taking more than 2 glucose lowering medications;
- ongoing medical treatment for diseases such as cancer, auto-immune or inflammatory disease, liver or kidney disorders;
- allergy, intolerance or aversion to eggs or any other dietary restrictions (e.g., vegan, breakfast skipping) that will prevent them from following the standardized study diets;
- being unable to follow remote guidance by internet or smartphone
- being unable to follow the controlled diet instructions;.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of British Columbialead
- University of Wollongongcollaborator
Study Sites (1)
University of British Columbia
Kelowna, British Columbia, V1V 1V7, Canada
Related Publications (1)
Oliveira BF, Chang CR, Oetsch K, Falkenhain K, Crampton K, Stork M, Hoonjan M, Elliott T, Francois ME, Little JP. Impact of a Low-Carbohydrate Compared with Low-Fat Breakfast on Blood Glucose Control in Type 2 Diabetes: A Randomized Trial. Am J Clin Nutr. 2023 Jul;118(1):209-217. doi: 10.1016/j.ajcnut.2023.04.032. Epub 2023 May 29.
PMID: 37257563DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Jonathan Little
- Organization
- University of British Columbia
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
July 15, 2020
First Posted
September 16, 2020
Study Start
October 1, 2020
Primary Completion
June 30, 2022
Study Completion
June 30, 2022
Last Updated
February 4, 2025
Results First Posted
February 4, 2025
Record last verified: 2025-02